Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector

A. Cara, S. M. Rybak, D. L. Newton, R. Crowley, S. E. Rottschafer, M. S. Reitz, G. L. Gusella

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

An HIV-l-based expression vector has been constructed that produces protective genes tightly regulated by HIV-1 Tat and Rev proteins. The vector contains either a single protective gene (HIV-1 gag dominant negative mutant (delta-gag)) or a combination of two different protective genes (delta-gag and eosinophil-derived neurotoxin (EDN) a human ribonuclease) which are expressed from a dicistronic mRNA. After stable transfection of CEM T cells and following challenge with HIV-1, viral production was completely inhibited in cells transduced with the vector producing both delta-gag and EDN and delayed in cells producing delta-gag alone. In addition, cotransfection of HeLa-Tat cells with an infectious HIV-1 molecular clone and either protective vector demonstrated that the HIV-1 packaging signals present in the constructs were functional and allowed the efficient assembly of the protective RNAs into HIV-1 virons, thus potentially transmitting protection to the HIV-1 target cells.

Original languageEnglish
Pages (from-to)65-75
Number of pages11
JournalGene Therapy
Volume5
Issue number1
DOIs
StatePublished - 1998
Externally publishedYes

Keywords

  • Gene therapy
  • HIV-1
  • Internal ribosome entry site
  • Replication
  • Ribonuclease

Fingerprint

Dive into the research topics of 'Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector'. Together they form a unique fingerprint.

Cite this